Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMedOpen access

Can a combination of nanofat and freeze-dried human amniotic membrane enhance full-thickness wound healing? An animal study using rabbit models.

Hidayati CA., Saputro ID., Budi AS.

Randomized Controlled Trial on Chronic Wound, published in Narra J (2024) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Narra J (2024)
Country
Indonesia
Reported sample size
—
Source database
PubMed
PMID
39816099
PMCID
PMC11731814
DOI
10.52225/narra.v4i3.1157

Abstract (original English)

Previous studies have explored nanofat stimulating tissue regeneration and maturation, promoting remodeling through its rich content of growth factors and stem cells; however, comprehensive data on its use in full-thickness wounds remains limited. The aim of this study was to evaluate the effectiveness of combining nanofat with freeze-dried human amniotic membrane (FDHAM) for treating full-thickness wounds in a rabbit model. An animal experimental study using a post-test control group design was conducted. Thirty-six male New Zealand white rabbits ( Oryctolagus cuniculus ) were randomly assigned to two groups: the experimental group (received a combination of nanofat and FDHAM) and the control group (received FDHAM alone). Each group was subdivided to evaluate effects on days 3 and 7. Macroscopic evaluations of wound healing, microscopic assessment of epithelialization and measurement of epidermal growth factor (EGF) levels in the wounds were conducted on days 3 and 7 post-injury. The present study indicated that the combination treatment significantly elevated EGF levels in the wounds on both days 3 and 7 (with p < 0.001 for both assessment time points). The combination of nanofat-FDHAM did not significantly accelerate epithelialization on either day 3 or 7. This study highlights that combining nanofat with FDHAM did not significantly speed up epithelialization of full-thickne

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AnimalsRabbitsAmnionWound HealingHumansFreeze DryingMaleEpidermal Growth FactorDisease Models, AnimalBiological Dressings

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research